AZD4635

AZD4635 · AstraZeneca

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AZD4635, covering 2022-07-08 to 2023-08-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC. [Phase 2]